Citations 2

A comparison of human natural monoclonal antibodies and aptamer conjugates for promotion of CNS remyelination: where are we now and what comes next?

Expert Opinion on Biological Therapy | February 23, 2018 | Volume: 18 | Issue: 5 | Pages: 545-560

10.1080/14712598.2018.1441284 | PMID 29460650

A Natural Human Monoclonal Antibody Protects from Axonal Injury in Different CNS Degenerative Disease Models

Future Neurology | January 17, 2018 | Volume: 13 | Issue: 1 | Pages: 23-29

10.2217/fnl-2017-0027